Heartbeat Tech Inc. develops medical devices to improve outcomes for sudden cardiac arrest patients. Their first product, The SAVER, is a CPR adjunct device designed to increase survival rates and minimize neurological impairment following cardiac arrest.
Funding
Funding not disclosed
Founders
Product
Problem
Sudden cardiac arrest affects over 650,000 individuals annually in the United States, with a high mortality rate and significant risk of neurological impairment among survivors. Conventional cardiopulmonary resuscitation (CPR) techniques have seen limited advancements since their introduction, resulting in suboptimal outcomes despite education and technological improvements in the field.
Solution
Heartbeat Tech is developing The SAVER™, a CPR adjunct device designed to improve outcomes in cardiac arrest patients by preferentially redirecting blood perfusion to vital organs. This non-invasive, patent-pending device aims to enhance survival rates and minimize neurological damage by optimizing blood flow to the heart and brain during CPR. The SAVER™ is engineered for ease of use, allowing for seamless integration with existing CPR protocols in both pre-hospital and hospital settings. The device is intended to be readily available wherever automated external defibrillators (AEDs) are deployed.
Target Audience
The primary target audience includes emergency medical service (EMS) providers, hospital emergency departments, and other healthcare professionals involved in the resuscitation of cardiac arrest patients.
Features
- Non-invasive CPR adjunct device designed for easy application during resuscitation efforts.
- Aims to preferentially redirect blood perfusion to the heart and brain.
- Compatible with existing CPR protocols and can be deployed in both pre-hospital and hospital environments.
- Patent-pending technology.
- Designed through a human-centered design process, incorporating feedback from medical professionals.